Evidence map›Paper›PMID 38631831›Full record

ReviewBMJ open2024

COVID-19 vaccine acceptance in the general population and under-resourced communities from high-income countries: realist review.

Nathalia Gonzalez-Jaramillo, Dominik Abbühl, Zayne Milena Roa-Díaz, Cristopher Kobler-Betancourt, Annika Frahsa

Abstract readReview
In one paragraph

Review in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathalia Gonzalez-JaramilloISPM, University of Bern, Bern, Switzerland nathalia.gonzalez-jaramillo@cslbehring.com.ORCID 0000-0003-4975-4439
Dominik AbbühlISPM, University of Bern, Bern, Switzerland.
Zayne Milena Roa-DíazISPM, University of Bern, Bern, Switzerland.
Cristopher Kobler-BetancourtISPM, University of Bern, Bern, Switzerland.
Annika FrahsaISPM, University of Bern, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare vaccination willingness before rollout and 1 year post-rollout uptake among the general population and under-resourced communities in high-income countries.

designA realist review. DATA SOURCES: Embase, PubMed, Dimensions ai and Google Scholar.

settingHigh-income countries. DEFINITIONS: We defined

resultsWe included data from 62 studies and 18 high-income countries. For studies conducted among general populations, the proportion of vaccination willingness was 67% (95% CI 62% to 72%). In real-world settings, the overall proportion of vaccine uptake among those countries was 73% (95% CI 69% to 76%). 17 studies reported pre-rollout willingness for under-resourced communities. The summary proportion of vaccination willingness from studies reporting results among people from under-resourced communities was 52% (95% CI 0.46% to 0.57%). Real-world evidence about vaccine uptake after rollout among under-resourced communities was limited.

conclusionOur review emphasises the importance of realist reviews for assessing vaccine acceptance. Limited real-world evidence about vaccine uptake among under-resourced communities in high-income countries is a call to context-specific actions and reporting.

Indexed as

COVID-19COVID-19 VaccinesDeveloped CountriesHumansIncomeVaccinationCOVID-19 VaccinesCOVID-19Meta-AnalysisVaccination

Identifiers

PMID38631831
PMCPMC11029206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.